SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-007845
Filing Date
2014-11-07
Accepted
2014-11-07 16:45:23
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_relmadatherapeutics.htm 10-Q 263057
2 CERTIFICATION f10q0914ex31i_relmada.htm EX-31.1 17325
3 CERTIFICATION f10q0914ex31ii_relmada.htm EX-31.2 17269
4 CERTIFICATION f10q0914ex32i_relmada.htm EX-32.1 6644
5 CERTIFICATION f10q0914ex32ii_relmada.htm EX-32.2 6684
  Complete submission text file 0001213900-14-007845.txt   2934240

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE relm-20140930.xml EX-101.INS 367140
7 XBRL SCHEMA FILE relm-20140930.xsd EX-101.SCH 27813
8 XBRL CALCULATION FILE relm-20140930_cal.xml EX-101.CAL 24175
9 XBRL DEFINITION FILE relm-20140930_def.xml EX-101.DEF 119538
10 XBRL LABEL FILE relm-20140930_lab.xml EX-101.LAB 273854
11 XBRL PRESENTATION FILE relm-20140930_pre.xml EX-101.PRE 188626
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-184881 | Film No.: 141205460
SIC: 2834 Pharmaceutical Preparations